Notably, Sirt1 expression is reduced in IBD tissue and activation of Sirt1 attenuates inflammatory signals in the gut, raising the possibility that such a defect could contribute to perpetuate pathogenic responses in the gut (10). Here, SIRT1 is linked to inflammatory bowel disease.